Literature DB >> 23052742

Renoportal anastomosis in right lobe living donor liver transplantation: report of a case.

Yoshihiro Matsumoto1, Toru Ikegami, Kazutoyo Morita, Tomoharu Yoshizumi, Hiroto Kayashima, Ken Shirabe, Yoshihiko Maehara.   

Abstract

End-stage liver disease is often accompanied by thrombosis of the portal vein and the formation of splanchnic collateral vessels. Successful liver transplantation in such situations is more likely if the surgeon uses a strategy to establish a graft inflow. A 59-year-old male with a decompensated liver secondary to idiopathic portal hypertension underwent living donor liver transplantation (LDLT) using a right lobe liver graft donated from his son. His portal venous trunk was atrophied and a splenorenal shunt drained the mesenteric venous flow into the systemic circulation. LDLT was performed with renoportal anastomosis (RPA) using his right internal jugular vein as an interposed venous graft, without dissecting the collateral vessels. Although he developed temporary functional hyperbilirubinemia, he was discharged from the hospital 23 days after LDLT. This case suggests that RPA is a useful technique to manage patients with an obstructed portal vein and a splenorenal shunt.

Entities:  

Mesh:

Year:  2012        PMID: 23052742     DOI: 10.1007/s00595-012-0351-1

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  15 in total

1.  Implications of portal vein thrombosis after splenectomy for patients with idiopathic portal hypertension.

Authors:  Teijiro Hirashita; Masayuki Ohta; Seiichiro Kai; Takashi Masuda; Hidetoshi Eguchi; Yukio Iwashita; Tadashi Ogawa; Seigo Kitano
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

2.  Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation.

Authors:  Ernesto P Molmenti; Thomas W Roodhouse; Hebe Molmenti; Kshama Jaiswal; Ghap Jung; Shigeru Marubashi; Edmund Q Sanchez; Brian Gogel; Marlon F Levy; Robert M Goldstein; Carlos G Fasola; Eric E Elliott; Nevenka Bursac; David Mulligan; Thomas A Gonwa; Goran B Klintmalm
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

3.  How to handle a huge portosystemic shunt in adult living donor liver transplantation with a small-for-size graft: report of a case.

Authors:  Yasumasa Shirouzu; Yuki Ohya; Yukika Tsukamoto; Hidekazu Yamamoto; Kwang-Jong Lee; Hideaki Okajima; Katsuhiro Asonuma; Yukihiro Inomata
Journal:  Surg Today       Date:  2009-06-28       Impact factor: 2.549

4.  Side-to-end renoportal anastomosis using an externally stented polytetrafluoroethylene vascular graft for a patient with a phlebosclerotic portal vein and a large spontaneous splenorenal shunt.

Authors:  Deok-Bog Moon; Sung-Gyu Lee; Chul-Soo Ahn; Tae-Yong Ha; Gil-Chun Park; Young-Dong Yu
Journal:  J Am Coll Surg       Date:  2011-03       Impact factor: 6.113

5.  Living donor liver transplantation with extensive caval thrombectomy for acute-on-chronic Budd-Chiari syndrome.

Authors:  Akihiko Soyama; Susumu Eguchi; Katsuhiko Yanaga; Mitsuhisa Takatsuki; Masaaki Hidaka; Takashi Kanematsu
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

6.  Ligation of left renal vein for large spontaneous splenorenal shunt to prevent portal flow steal in adult living donor liver transplantation.

Authors:  Sung-Gyu Lee; Deok-Bog Moon; Chul-Soo Ahn; Ki-Hun Kim; Shin Hwang; Kwang-Min Park; Tae-Yong Ha; Gi-Young Ko; Kyu-Bo Sung; Gi-Won Song; Dong-Hwan Jung; Ki-Myung Moon; Bum-Soo Kim; Yong-Pil Cho
Journal:  Transpl Int       Date:  2007-01       Impact factor: 3.782

7.  Liver transplantation with renoportal anastomosis after distal splenorenal shunt.

Authors:  T Kato; D M Levi; W DeFaria; S Nishida; A G Tzakis
Journal:  Arch Surg       Date:  2000-12

Review 8.  Current concept of small-for-size grafts in living donor liver transplantation.

Authors:  Toru Ikegami; Mitsuo Shimada; Satoru Imura; Yusuke Arakawa; Akira Nii; Yuji Morine; Hirofumi Kanemura
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

9.  Explanted portal vein grafts for middle hepatic vein tributaries in living-donor liver transplantation.

Authors:  Toru Ikegami; Yuji Soejima; Akinobu Taketomi; Tomoharu Yoshizumi; Noboru Harada; Hideaki Uchiyama; Mitsuo Shimada; Yoshihiko Maehara
Journal:  Transplantation       Date:  2007-10-15       Impact factor: 4.939

10.  Natural history of recurrent hepatitis C.

Authors:  Marina Berenguer
Journal:  Liver Transpl       Date:  2002-10       Impact factor: 5.799

View more
  4 in total

1.  Adult Living Donor Liver Transplantation for Patients With Portal Vein Thrombosis: A Single-center Experience.

Authors:  Kohei Miura; Yasuhiko Sugawara; Koushi Uchida; Seiichi Kawabata; Daiki Yoshii; Kaori Isono; Shintaro Hayashida; Yuki Ohya; Hidekazu Yamamoto; Takashi Kobayashi; Toshifumi Wakai; Yukihiro Inomata; Taizo Hibi
Journal:  Transplant Direct       Date:  2018-04-13

2.  The Role of Cavoportal and Renoportal Hemitransposition in Liver Transplantation.

Authors:  Betty Maillot; Guillaume Bouzille; Jean-Yves Mabrut; Edouard Girard; Alexis Laurent; Francis Navarro; Alexandre Chebaro; Laurence Chiche; Francois Faitot; Laurent Sulpice; Eric Vibert; Karim Boudjema
Journal:  Ann Transplant       Date:  2022-03-08       Impact factor: 1.530

3.  Renoportal Anastomosis in Left Lateral Lobe Living Donor Liver Transplantation: A Pediatric Case.

Authors:  Hiroyuki Ogasawara; Chikashi Nakanishi; Shigehito Miyagi; Kazuaki Tokodai; Yasuyuki Hara; Wataru Nakanishi; Koji Miyazawa; Kenji Shimizu; Hiroyuki Kumata; Hitoshi Goto; Masafumi Goto; Michiaki Unno; Takashi Kamei
Journal:  Case Rep Gastroenterol       Date:  2017-09-27

Review 4.  Living donor liver transplantation for idiopathic portal hypertension with extrahepatic portal vein stenosis and splenic artery aneurysms: a case report and review of the literature.

Authors:  Shigeyuki Kawachi; Naokazu Chiba; Masashi Nakagawa; Toshimichi Kobayashi; Kosuke Hikita; Toru Sano; Koichi Tomita; Hiroshi Hirano; Yuta Abe; Hideaki Obara; Motohide Shimazu
Journal:  BMC Surg       Date:  2020-10-29       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.